Plus Therapeutics, Inc. (NASDAQ:PSTV – Get Rating)’s share price traded up 3.9% on Wednesday . The company traded as high as $4.13 and last traded at $4.02. 14,370 shares changed hands during trading, a decline of 41% from the average session volume of 24,545 shares. The stock had previously closed at $3.87. Wall Street Analyst […]
Plus Therapeutics (NASDAQ:PSTV – Get Rating) had its target price lowered by Maxim Group from $30.00 to $12.00 in a report issued on Wednesday, The Fly reports. Separately, HC Wainwright reissued a buy rating and set a $52.50 price target on shares of Plus Therapeutics in a report on Friday, April 21st. Plus Therapeutics Stock […]
Plus Therapeutics (NASDAQ:PSTV – Get Rating) had its price objective cut by Maxim Group from $30.00 to $12.00 in a research note issued to investors on Wednesday morning, The Fly reports. Separately, HC Wainwright reaffirmed a buy rating and issued a $52.50 price target on shares of Plus Therapeutics in a report on Friday, April […]
Plus Therapeutics (NASDAQ:PSTV – Get Rating) had its price target lowered by equities research analysts at Maxim Group from $30.00 to $12.00 in a note issued to investors on Wednesday, The Fly reports. Maxim Group’s target price would suggest a potential upside of 212.50% from the stock’s previous close. Separately, HC Wainwright restated a “buy” […]
Plus Therapeutics, Inc. (NASDAQ:PSTV – Get Rating) – Equities researchers at HC Wainwright issued their Q1 2024 earnings estimates for Plus Therapeutics in a research report issued to clients and investors on Friday, April 21st. HC Wainwright analyst S. Lee expects that the company will post earnings per share of ($0.09) for the quarter. HC […]